Information Hub

Event
Partner
Milestone
Event
2018-03-31

Jul 02-03 ACT Genomics unlocks the value of comprehensive genomic profiling in World Medicine 2018

Unlock the value of comprehensive genomic profiling: lessons and case studies in cancer management

Place:

Thailand

Event
2018-03-31

May 05-06 Novel treatment strategies in precision cancer medicine in TJCC

ACT Genomics invites the Deputy Director of Tokyo Medical and Dental University Cancer Center, Dr. Sadakatsu Ikeda as guest speaker and the Director of National Taiwan Hospital Graduate Institute of Oncology, Dr. James Chih-Hsin Yang as moderator, to shar

Place:

Taipei

Event
2018-03-31

Apr 04&06 ACT Genomics is invited to share promises and challenges of NGS in Singapore

Dr. Maarja-Liisa Nairismagi will be sharing on the topic, Can Next Generation Sequencing Fulfill its Promises in Cancer Management in the Era of Precision Medicine and promises and challenges of Next Generation Sequencing in cancer management.

Place:

Singapore

Event
2018-03-31

Mar 23 An exemplary high-tech biomedical enterprise in Southeast Asia

ACT Genomics successfully positions itself as an exemplary high-tech enterprise for Taiwan’s biomedical companies in their south bound strategy to clinch the emerging market

Place:

Singapore

Event
2018-03-31

Mar 20 Finding a way to avoid genetic discrimination

Dr. Shu-Jen Chen, Chief Scientific Officer of ACT Genomics joined oncologists to explore detection of germline mutations with NGS, share cases of early cancer treatment, and discuss how to assist patients with hereditary genetic mutations to avoid genetic

Place:

Hong Kong

Event
2018-03-31

Mar 19 The rising star in Asia’s genomic profiling platform

Dr. Shu-Jen Chen, Chief Scientific Officer of ACT Genomics introduced how personal genomic information can be transformed into guidance for cancer treatment selection through their know-how, which attracted investors’ attention.

Place:

Japan

Event
2018-03-31

Mar 16 ACT Genomics shared NGS experiences in cancer management

. Dr. Maarja-Liisa Nairismagi shared on promises and challenges of Next Generation Sequencing in cancer management in Singapore

Place:

Singapore

Event
2018-03-31

Mar 09 NGS market insight for Economist Intelligence Unit

Dr. Allen Lai, Senior Vice President, has been interviewed by EIU on 9th March to provide his critical in-field observation of the trend and the adoption challenges of NGS in the years to come in Southeast Asia and beyond.

Place:

Singapore

Event
2018-03-31

Mar 09 Creating biomedical ecosystem to facilitate medical advances in Southeast Asia

Dr. Lai illustrate the importance of creating an enabling biomedical ecosystem to facilitate development and access to innovative medical advances in several countries in Asia.

Place:

Singapore

Event
2018-03-31

ACT Genomics shared knowledge on genetics of hematological malignancies

Dr. Maarja-Liisa Nairismagi shared knowledge on the genetics of hematological malignancies and the usage of tumor mutational burden (TMB) as a biomarker.

Place:

Singapore